INTERSECT ENT, INC.
MENLO PARK, CA

Founded on September 6, 2012, Intersect ENT, Inc. is at the forefront of transformative ear, nose, and throat (ENT) care with a mission centered on developing innovative therapies for both physicians and patients. Based in Minneapolis, MN, but mailing from Menlo Park in Florida, this biotechnology pioneer continues to lead its field. The company holds an official registration under Delaware law with FEI Number: 200280837 and is incorporated in Florida as file number F12000003661. Intersect ENT values direct communication regarding ideas or suggestions about their products or technologies but requires all such feedback be submitted formally. This policy ensures clear communications while maintaining legal protections for both the company and its collaborators. In keeping with these principles, Intersect commits to transparency in all business dealings without being bound to review unsolicited submissions unless a formal agreement exists. At the helm of Intersect ENT are key leaders like President Amy Van Sach and Vice Presidents Anna Vincent and Danyel J Racenet, each contributing strategically to the company’s direction. You can reach out via multiple contact numbers: (650) 641-2100, (866) 531-6004, (650) 641-2105, or (650) 454-0504. To explore their offerings, check out intersectent.com. Reflecting its dedication to governance and compliance, Intersect ENT filed its latest annual report on April 17, 2024.